Medtronic's implantable cardiac monitors recommended on ... | 合法醫療器材資訊網

2020年1月14日—ThecostoftheRevealLINQis£1,800plusthecostofimplantingthedevice.Itwasassumedintheassessmentthatpeoplewithanimplantable ...

Hundreds of strokes of unknown cause could be prevented with a new implantable cardiac monitor that transmits data to doctors remotely, following the publication of draft NICE guidance.

The Reveal LINQ monitor – developed by Medtronic – identifies more people who have atrial fibrillation[1] (AF) after a cryptogenic stroke [a stroke with no identified cause] or transient ischaemic attack (TIA).

One-third of the size of a AAA battery, it is implanted under the skin in the chest usually under local anaesthetic, to track a heart’s activity over long periods of time, transmitting data back to the patient’s doctor via a mobile phone network.

Undiagnosed atrial fibrillation is believed to be responsible for a significant portion of the 30,000 cryptogenic strokes that occur each year in the United Kingdom.

Cryptogenic stroke patients have a high risk of recurrent strok...